EBIT Margin (Quarterly)

EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues

Elanco Animal Health Incorporated (ELAN) had EBIT Margin of 11.16% for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$1.37B
Net Income	$57.00M
Cost of Goods Sold	$586.00M
Gross Profit	$785.00M
Operating Expenses	$1.22B
Operating Income	$153.00M
Non-Operating Income/Expense	$-66.00M
Pre-Tax Income	$87.00M
Normalized Pre-Tax Income	$87.00M
Income after Taxes	$57.00M
Income from Continuous Operations	$57.00M
Consolidated Net Income/Loss	$57.00M
Normalized Income after Taxes	$57.00M
EBIT	$153.00M
EBITDA	$325.00M
Weighted-Average Shares Outstanding (Basic)	497.70M
Weighted-Average Shares Outstanding (Diluted)	506.00M
Earnings per Share (EPS) (Basic)	$0.11
Earnings per Share (EPS) (Diluted)	$0.11
Balance Sheet Financials
Current Assets	$3.58B
Property, Plant, and Equipment	$1.40B
Long-Term Assets	$9.64B
Total Assets	$13.22B
Current Liabilities	$1.66B
Long-Term Debt	$3.92B
Long-Term Liabilities	$5.06B
Total Liabilities	$6.72B
Common Equity	$6.50B
Tangible Shareholders Equity	$-1.45B
Shareholders Equity	$6.50B
Common Shares Outstanding	499.38M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$13.00M
Cash Flow from Investing Activities	$-60.00M
Cash Flow from Financial Activities	$-65.00M
Beginning Cash	$545.00M
End Cash	$428.00M
Increase/Decrease in Cash	$-117.00M
Stock-Based Compensation	$21.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.16
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.38
Debt to Equity Ratio	0.61
Gross Margin	57.26%
Operating Margin	11.16%
EBIT Margin	11.16%
EBITDA Margin	--
Pre-Tax Profit Margin	6.35%
Profit Margin	4.16%
Free Cash Flow	$-38.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.10
Inventory Turnover	0.34
Receiveable Turnover	1.19
Days Sales in Receivables	75.75
Return on Equity	0.88%
Return on Tangible Equity	-3.94%
Return on Assets	0.43%
Return on Investments	0.55%
Book Value Per Share	$13.02
Free Cash Flow per Share	$-0.08
Operating Cash Flow per Share	$0.03

Data from Zacks Investment Research, Inc.